Synthetic polyamines as potential amine oxidase inhibitors: A preliminary study

Amino Acids

Volumn 42, Issue 2-3, 2012, Pages 913-928

  Emanuela, Bonaiuto ^a   Minarini, Anna ^b   Tumiatti, Vincenzo ^b   Milelli, Andrea ^b   Lunelli, Michele ^c   Pegoraro, Maurizio ^d   Rizzoli, Valeria ^a   Di Paolo, Maria Luisa ^a,e  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d SAN BORTOLO HOSPITAL   (Italy)

^e NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

Amine oxidase inhibitors; Monoamine oxidase B; Semicarbazidesensitive amine oxidases; Structure function relationships; Synthetic polyamines

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ELP 12; ELP12; MONOAMINE OXIDASE INHIBITOR; N,N' DIBENZYLDODECANE 1,12 DIAMINE; POLYAMINE DERIVATIVE; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1; ENZYME INHIBITOR; POLYAMINE;

ALZHEIMER DISEASE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; CIRCULAR DICHROISM; DRUG ANTAGONISM; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; KINETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AMINE OXIDASE (COPPER-CONTAINING); CIRCULAR DICHROISM; ENZYME INHIBITORS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MONOAMINE OXIDASE; POLYAMINES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84861665859     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1006-z     Document Type: Article

References (59)

1. Atkins PW (1986) Equilibrium electrochemistry: ions and electrodes. In physical chemistry, 3rd edn. Oxford University Press, Oxford, pp 242-243
2. Bianchi M, Polticelli F, Ascenzi P, Botta M, Federico R, Mariottini P, Cona A (2006) Inhibition of polyamine and spermine oxidases by polyamine analogues. FEBS J 273:1115-1123. doi: 10.1111/j.1742-4658.2006.05137.x (Pubitemid 43345033)
3. Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 50:5848-5852. doi:10.1021/jm070677y (Pubitemid 350106038)
4. Bonaiuto E, Lunelli M, Scarpa M, Vettor R, Milan G, Di Paolo ML (2010) A structure- activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/ VAP-1 enzyme. Biochimie 92:858-868. doi:10.1016/j.biochi. 2010.03.006
5. Bonivento D, Milczek EM, McDonald GR, Binda C, Holt A, Edmondson DE, Mattevi A (2010) Potentiation of ligand binding through cooperative effects in monoamine oxidase B. J Biol Chem 285:36849-36856. doi:10.1074/jbc.M110.169482
6. Boomsma F, Bhaggoe UM, van der Houwen AMB, van den Meiracker AH (2003) Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology. Biochim Biophys Acta 1647:48-54. doi:10.1016/51570-9639(03)00047-5 (Pubitemid 38234631)
7. Bortolato M, Chen K, Shih JC (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60:1527-1533. doi:10.1016/j.addr.2008.06.002
8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
9. Carreiras MC, Marco JL (2004) Recent approaches to novel anti- Alzheimer therapy. Curr Pharm Des 10:3167-3175 (Pubitemid 39242911)
10. Casero RA, Woster PM (2009) Recent advances in the development of polyamine analogues as antitumor agents. J Med Chem 52:4551-4573. doi:10.1021/jm900187v
11. Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C (2008) Multi-target-directed ligand to combact neurodegenerative diseases. J Med Chem 51:347-372. doi:10.1021/jm7009364 (Pubitemid 351252260)
12. Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D66:12-21. doi:10.1107/S09 07444909042073
13. Clauzel LM, Font FY, Vicente SG, Exposito MR, Palomera FA, Olarte AZ (2007) Carboxamides and related compounds for inhibiting copper-containing amine oxidases and their preparation, pharmaceutical compositions and use in the treatment of diseases US. Pat Appl Publ US 20070066646 A1 20070322
14. Cohen RA, Tong XY (2010) Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol 55:308-316
15. Compton LA, Johnson WC Jr (1986) Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication. Anal Biochem 155:155-167. doi:10.1016/0003-2697(86)90241 (Pubitemid 16034476)
16. Di Paolo ML, Lunelli M, Scarpa M, Rigo A (2004) Phosphonium compounds as new and specific inhibitors of bovine serum amine oxidase. Biochem J 384:551-558. doi:10.1042/BJ20031883 (Pubitemid 40018968)
17. Di Paolo ML, Pesce C, Lunelli M, Scarpa M, Rigo A (2007) N-alkanamines as substrates to probe the hydrophobic region of bovine serum amine oxidase: a kinetic and spectroscopic study. Arch Biochem Biophys 465:50-60. doi:10.1016/j.abb.2007. 04.031 (Pubitemid 47283978)
18. Dunkel P, Gelain A, Barlocco D, Haider N, Gyires K, Perlagh B, Magyar K, Maccioni E, Fadda A, Matyus P (2008) Semicarbazide- sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. Curr Med Chem 15:1827-1839. doi:0929-8673/08
19. Edmonsons DE, Binda C, Wang J, Upadyay AK, Mattevi A (2009) Molecular and mechanistic properties of mitochondrial monoamine oxidases. Biochemistry 48:4220-4230. doi:10.1021/ bi900413g
20. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of coot. Acta Crystallogr D66:486-501. doi: 10.1107/S0907444910007493
21. Ferrer I, Lizcano JM, Hernández M, Unzeta M (2002) Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurosci Lett 321:21-24. doi:10.1016/ S0304-3940(01)02465-X (Pubitemid 34185489)
22. Gubisne-Haberle D, Hill W, Kazachkov M, Richardson JS, Yu PH (2004) Protein cross-linkage induced by formaldehyde derived from semicarbazide- sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther 310:1125-1132 (Pubitemid 39108934)
23. Haider N, Hochholdinger I, Matyus O, Wobus A (2010) Synthesis of ortho-functionalized 4-Aminomethylpyridazines as substratelike semicarbazide-sensitive amine oxidase inhibitors. Chem Pharm Bull 58:964-970. doi:10.1248/cpb.58.964
24. Holt A, Degenhardt OS, Berry PD, Kapty JJ, Mithani S, Smith DJ, Di Paolo ML (2007) The effects of buffer cations on interactions between mammalian copper-containing amine oxidases and their substrates. J Neural Transm 114:733-741. doi:10.1007/s00702-007-0680-1 (Pubitemid 46980477)
25. Holt A, Smith DJ, Cendron L, Zanotti G, Rigo A, Di Paolo ML (2008) Multiple binding sites for substrates and modulators of semicarbazide- sensitive amine oxidases: kinetic consequences. Mol Pharm 73:525-538. doi:10.1124/mol.107.040964 (Pubitemid 351181186)
26. Huey R, Morris GM, Olson AJ, Goodsell DS (2007) A semiempirical free energy force field with charge-based desolvation. J Comput Chem 28:1145-1152. doi:10.1002/jcc.20634 (Pubitemid 46506716)
27. Jakobsson E, Nilsson J, Ogg D, Kleywegt GJ (2005) Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1. Acta Crystallogr D61:1550-1562. doi:10.1107/s1744 309105002678 (Pubitemid 44210920)
28. Jalkanen S, Salmi M (2001) Cell surface monoamine oxidases: enzymes in search of a function. EMBO J 20:3893-3901. doi: 10.1093/emboj/20.15.3893 (Pubitemid 32751805)
29. Jalkanen S, Salmi M (2008) VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol 28:18-26. doi:10.1161/ATVBAHA.107.153130
30. Kinemuchi H, Sugimoto H, Obata T, Satoh N, Ueda S (2004) Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues. Neurotoxicology 25:325-335. doi:10.1016/S0161- 813X(03)00118-9 (Pubitemid 38044193)
31. Leidler K, Bunting P (1973) The chemical kinetics of enzyme action, 2nd edn. Clarendon Press, Oxford, pp 89-138
32. Lobley A, Withmore L, Wallace BA (2002) DICHROWEB: an interative Website for the analysis of protein secondary structure from Circular Dichroism Data. Bioinformatics 18:211-212 (Pubitemid 34145057)
33. Lovell SC, Word JM, Richardson JS, Richardson DC (2000) The penultimate rotamer library. Proteins 40:389-408. doi:10.1002/ 1097-0134(20000815) (Pubitemid 30624447)
34. Lühr S, Vilches-Herrera M, Fierro A, Ramsay RR, Edmonson DE, Reyes-Parada M, Cassels BK, Iturriaga-Vasquez P (2010) 2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors. Bioinorg Med Chem 18:1388-1395. doi:10.1016/j.bmc.2010.01.029
35. Melchiorre C, Andrisano M, Bolognesi ML, Budriesi R, Cavalli A, Cavrini V, Rosini M, Tumiatti V, Recanatini M (1998) Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease. J Med Chem 41:4186-4189. doi:10.1021/jm9810542 (Pubitemid 28498739)
36. Melchiorre C, Bolognesi ML, Minarini A, Rosini M, Tumiatti V (2010) Polyamines in drugs discovery: from the universal template approach to the multitarget-directed ligand design strategy. J Med Chem doi:10.1021/jm100293f
37. Minarini A, Quaglia W, Tumiatti V, Melchiorre C (1989) An improved synthesis of N,N0-Bis[6-[[(2-methoxyphenyl) methyl]amino]hexyl]-1,8octanediamine (Methoctramine). Chem Ind 652-653
38. Minarini A, Milelli A, Tumiatti V, Rosini M, Bolognesi ML, Melchiorre C (2010) Synthetic polyamines: an overview of their multiple biological activities. Amino Acids 38:383-392. doi: 10.1007/s00726-009-0430-9
39. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem 19:1639-1662 (Pubitemid 128590223)
40. Mutsuhiko Y, Yasuhara H (2004) Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicol 25:215-221. doi: 10.1016/S0161-813X(03)00097-4 (Pubitemid 38044183)
41. Nurminen EM, Pihlavisto M, Lázár L, Szakonyi Z, Putikäinen U, Fülöp F, Putikäinen OT (2010) Synthesis, in vitro activity, and three-dimensional quantitative structure-activity relationship of novel hydrazine inhibitors of human vascular adhesion protein-1. J Med Chem 53:6301-6315. doi:10.1021/jm100337z
42. Olarte AZ, Mian A, Clauzel LM, Exposito MR, Fonte FY, Palomera FA (2006) Compounds for inhibiting copper-containing amine oxidases and their use in inflammatory disease. Int Appl WO 2006013209, A2 20060209
43. Padiglia A, Medda R, Lorrai A, Paci A, Pedersen JZ, Boffi A, Bellelli A, Finazzi Agro' A, Floris G (2001) Irreversible inhibition of pig kidney copper-containing amine oxidase by sodium and lithium ions. Eur J Biochem 268:4686-4697. doi:10.1046/j.1432-1327. 2001.02390.x (Pubitemid 34203417)
44. Prins LH, Petzer JP, Malan SF (2010) Inhibition of monoamine oxidase by indole and benzofuran derivatives. Eur J Med Chem 45:4458-4466. doi:10.1016/j.ejmech.2010.07.005
45. Sahoo A, Yobanoglu S, Sinha BN, Ucar G, Basu A, Jayaparkash V (2010) Towards development of selective and reversibile pyrazoline based MAO-inhibitors: synthesis, biological evaluation and docking studies. Bioorg Med Chem Lett 20:132-136. doi:10.1016/j.bmcl.2009.11.015
46. Smith DJ, Fulop F, Pihlavisto M, Lazar L, Alaranta S, Vainio PJ, Szakonyi ZS (2003) Carbocyclic hydrazino inhibitors of coppercontaining amine oxidases. Int Pat Appl WO 03/006003 A1; Chem Abstr 138, 57890
47. Sreerama N, Woody RW (2000) Estimation of protein secondary structure from CD spectra: comparison of CONTIN, SELCON and CDSSTR methods with an expanded reference set. Anal Biochem 287:252-260. doi:10.1006/abio.2000.4880 (Pubitemid 32006234)
48. Tumiatti V, Minarini A, Milelli A, Rosini M, Buccioni M, Marucci G, Ghelardini C, Bellucci C, Melchiorre C (2007) Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties. Bioorg Med Chem 15:2312-2321. doi: 10.1016/j.bmc.2007.01.022 (Pubitemid 46240917)
49. Tumiatti V, Milelli A, Minarini A, Rosini M, Bolognesi ML, Micco M, Andrisano V, Bartolini M, Mancini F, Recanatini M, Cavalli A, Melchiorre C (2008) Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer. J Med Chem 5:7308-7312. doi:10.1021/jm8009684
50. Unzeta M, Solè M, Boada M, Hernandez M (2007) Semicarbazidesensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. J Neural Transm 114:857-862. doi:10.1007/s00702.007.07010 (Pubitemid 46980498)
51. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84 (Pubitemid 44566469)
52. Vavilova T, Ostrovskaya I, Axenova L, Buneeva O, Medvedev A (2009) Monoamine oxidase and semicarbazide sensitive amine oxidase activities in normal and inflamed human dental pulp. Med Sci Monit 15:BR289-BR292
53. Wang J, Edmondson DE (2007) Do monomeric vs dimeric forms of MAO-A make a difference? A direct comparison of the catalytic properties of rat and human MAO-A's. J Neural Transm 114:721-724. doi:10.1007/s00702-007-0678-8 (Pubitemid 46980475)
54. Wang EY, Gao A, Salter-Cid L, Zhang J, Huang L, Podar EM, Miller A, Zhao J, O'Rourke A, Linnik MD (2006) Design, synthesis and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. J Med Chem 49:2166-2173. doi:10.1021/jm050538l
55. Wellendorph P, Jaroszewski JW, Hansen SH, Franzyk H (2003) A sequential high-yielding large-scale solution-method for synthesis of philanthotoxin analogues. Eur J Med Chem 38:117-122. doi:10.1016/S0223-5234(02)00003-X (Pubitemid 36197860)
56. Youdim MB (2006) The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30. Curr Alzheimer Res 3:541-550 (Pubitemid 46066429)
57. Youdim MB, Buccafusco JJ (2005) CNS targets for multifunctional drugs in the treatment of Alzheimer's and Parkinson's diseases. J Neural Transm 112:519-537. doi:10.1007/s00702-004-0214-z (Pubitemid 40562085)
58. Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D (2003) Physiological and pathological implications of semicarbazidesensitive amine oxidase. Biochim Biophys Acta 11(1647): 193-199 (Pubitemid 38234655)
59. Zhou M, Panchuck-Voloshina NA (1997) A one-step fluorimetric method for the continuous measurement of monoamine oxidase activity. Anal Biochem 253:169-174. doi:10.1006/abio.1997. 2392 (Pubitemid 27508168)